NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
Clinical trial NCT07227909 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07227909
- Sponsor
- M.D. Anderson Cancer Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-04
- Primary completion
- 2029-01-31
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.